These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 20827613

  • 1. [Levodopa intestinal infusion therapy in Parkinson's disease].
    Sławek J, Bogucki A.
    Neurol Neurochir Pol; 2010; 44(4):396-403. PubMed ID: 20827613
    [Abstract] [Full Text] [Related]

  • 2. [Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].
    Toth A, Nagy H, Wacha J, Bereczki D, Takáts A.
    Neuropsychopharmacol Hung; 2015 Dec; 17(4):191-6. PubMed ID: 26727723
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.
    Raudino F, Garavaglia P, Pianezzola C, Riboldazzi G, Leva S, Guidotti M, Bono G.
    Neurol Sci; 2009 Feb; 30(1):85-6. PubMed ID: 19169622
    [No Abstract] [Full Text] [Related]

  • 5. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
    Wirdefeldt K, Odin P, Nyholm D.
    CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
    [Abstract] [Full Text] [Related]

  • 6. The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When?
    Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA.
    J Parkinsons Dis; 2020 May; 10(s1):S65-S73. PubMed ID: 32651333
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment possibilities in advanced Parkinson's disease].
    Takáts A, Nagy H, Radics P, Tóth A, Tamás G.
    Ideggyogy Sz; 2013 Nov 30; 66(11-12):365-71. PubMed ID: 24555235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Continuous treatment with levodopa of Parkinson disease].
    Lundqvist C, Nystedt T, Reiertsen O, Grotli R, Beiske AG.
    Tidsskr Nor Laegeforen; 2005 Oct 06; 125(19):2638-40. PubMed ID: 16215609
    [Abstract] [Full Text] [Related]

  • 11. [Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease].
    Santos-Garcia D, de Deus T, Lopez-Pazos E, Macias-Arribi M, Llaneza-Gonzalez MA, Echarri-Piudo A, Carpintero P, de la Fuente-Fernandez R.
    Rev Neurol; 2014 Jun 01; 58(11):505-15. PubMed ID: 24861226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A, Devos D, Seguy D, Dujardin K, Destée A, Defebvre L.
    Rev Neurol (Paris); 2009 Jun 01; 165(8-9):718-27. PubMed ID: 19150100
    [Abstract] [Full Text] [Related]

  • 14. Duodopa pump treatment in patients with advanced Parkinson's disease.
    Karlsborg M, Korbo L, Regeur L, Glad A.
    Dan Med Bull; 2010 Jun 01; 57(6):A4155. PubMed ID: 20515603
    [Abstract] [Full Text] [Related]

  • 15. Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.
    Zibetti M, Merola A, Ricchi V, Marchisio A, Artusi CA, Rizzi L, Montanaro E, Reggio D, De Angelis C, Rizzone M, Lopiano L.
    J Neurol; 2013 Jan 01; 260(1):105-14. PubMed ID: 22772358
    [Abstract] [Full Text] [Related]

  • 16. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.
    Antonini A, Fung VS, Boyd JT, Slevin JT, Hall C, Chatamra K, Eaton S, Benesh JA.
    Mov Disord; 2016 Apr 01; 31(4):530-7. PubMed ID: 26817533
    [Abstract] [Full Text] [Related]

  • 17. Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.
    Antonini A, Nitu B.
    J Neural Transm (Vienna); 2018 Aug 01; 125(8):1131-1135. PubMed ID: 30006821
    [Abstract] [Full Text] [Related]

  • 18. [Experience with continuous levodopa enteral infusion (Duodopa(®)) in patients with advanced Parkinson's disease in a secondary level hospital].
    Santos-García D, Macías M, Llaneza M, Fuster-Sanjurjo L, Echarri-Piudo A, Belmonte S, Blanco S.
    Neurologia; 2010 Aug 01; 25(9):536-43. PubMed ID: 21093702
    [Abstract] [Full Text] [Related]

  • 19. Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel.
    Marano M, Naranian T, di Biase L, Di Santo A, Poon YY, Arca R, Cossu G, Marano P, Di Lazzaro V, Fasano A.
    Parkinsonism Relat Disord; 2019 Dec 01; 69():140-146. PubMed ID: 31759188
    [Abstract] [Full Text] [Related]

  • 20. Continuous dopaminergic stimulation achieved by duodenal levodopa infusion.
    Odin P, Wolters E, Antonini A.
    Neurol Sci; 2008 Dec 01; 29 Suppl 5():S387-8. PubMed ID: 19381770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.